Shortness of Breath. When It Is Your Heart and When It Is Not.

Shortness of breath with exertion that has changed in quality over months deserves clinical evaluation. It is one of the most common presenting symptoms for both cardiac and pulmonary disease, and distinguishing them requires close attention to clinical features, not just to the symptom in isolation.

The Mechanism

The sensation of breathlessness, called dyspnea, arises when the demand placed on the respiratory system exceeds its current capacity. In healthy people, this capacity is large and the threshold is high. In people with cardiac disease, that threshold shifts downward, sometimes well before any other symptom appears.

The heart and lungs are mechanically coupled through the pulmonary circulation. When the left side of the heart fails to pump efficiently, pressure backs up from the left ventricle into the left atrium, then into the pulmonary veins, and finally into the lung capillaries. The result is pulmonary congestion: fluid leaking into the interstitium of the lung, stiffening the tissue and increasing the work of breathing. This is the mechanism of cardiac dyspnea in heart failure, and it begins long before the chest X-ray shows overt pulmonary edema.

In coronary artery disease, the mechanism is different. When exercise increases myocardial oxygen demand beyond what a diseased coronary artery can supply, the ischemic segment of heart muscle becomes transiently dysfunctional. A dysfunctional segment stiffens, raises filling pressures acutely, and produces the same pulmonary congestion, but transiently and specifically during the period of ischemia. This explains why exertional ischemia can present as breathlessness rather than chest pain: the sensation reflects the momentary rise in filling pressure, not nerve pain from the ischemic tissue itself.

In valvular disease, the mechanisms are specific to the lesion. Aortic stenosis creates a fixed outflow obstruction that limits cardiac output during exercise and produces dyspnea through reduced cardiac reserve. Mitral regurgitation produces chronic volume overload of the left atrium and elevated pulmonary venous pressure. Both produce exertional dyspnea that worsens progressively as the valvular lesion advances.

Pulmonary causes of dyspnea operate through a different pathway. Obstructive lung disease reduces expiratory flow and traps air. Pulmonary fibrosis reduces lung compliance and gas exchange surface area. Pulmonary arterial hypertension increases the right ventricular afterload. Each pathway produces breathlessness, but the associated symptoms, the timing within a breath, and the clinical context help distinguish them from cardiac causes.

Two additional cardiac mechanisms deserve specific mention because they are frequently overlooked. Cardiac arrhythmias, particularly paroxysmal atrial fibrillation, cause episodic dyspnea that appears suddenly, may last minutes to hours, and resolves completely. The man who describes episodes of breathlessness that come on without clear exertional correlation and resolve spontaneously warrants cardiac rhythm monitoring to evaluate for paroxysmal arrhythmia. Resting ECG has limited sensitivity for paroxysmal events; a 24-hour Holter monitor, or longer-duration ambulatory monitoring, is more appropriate.

Hypertrophic cardiomyopathy (HCM) is a structural condition in which the ventricular muscle is abnormally thick, reducing the filling capacity of the left ventricle and in some cases producing outflow obstruction. HCM causes exertional dyspnea, and in some patients, it causes dyspnea at rest when the obstruction worsens with certain positions or after eating. It is estimated to affect approximately one in 500 people and is the most common cause of sudden cardiac death in young athletes. HCM is identified on echocardiogram and warrants consideration in any man with unexplained dyspnea and a family history of sudden cardiac death.

Anemia is a non-cardiac cause of dyspnea that mimics cardiac dyspnea closely. When hemoglobin is low, the blood’s oxygen-carrying capacity is reduced. To compensate, cardiac output must increase to maintain oxygen delivery. This places strain on a heart that may already have limited reserve and produces breathlessness at lower exertion thresholds. A complete blood count should be part of the initial evaluation of unexplained dyspnea, because anemia is common, treatable, and frequently overlooked in middle-aged men who are not in the populations routinely screened for it.

What the Evidence Shows

The landmark study establishing biomarkers in the distinction of cardiac from non-cardiac dyspnea is the Breathing Not Properly (BNP) Multinational Study, published in the New England Journal of Medicine in 2002 by Maisel and colleagues. The study enrolled 1,586 patients presenting to emergency departments with dyspnea as their primary complaint. BNP at a cutoff of 100 pg/mL had a sensitivity of 90 percent and specificity of 76 percent for the diagnosis of heart failure. Negative predictive value was 89 percent. A BNP below 50 pg/mL essentially excluded heart failure as the cause of dyspnea. 4 / Promising

The Breathing Not Properly study also established that BNP outperformed clinical judgment alone. Physicians correctly identified heart failure in 74 percent of cases before BNP; adding BNP improved diagnostic accuracy to 81 percent. This is not a marginal improvement in a disease that affects millions of men and where early identification changes treatment and outcomes.

NT-proBNP, the N-terminal fragment of the same prohormone, is more stable and has a longer half-life. The PRIDE study (Pro-BNP Investigation of Dyspnea in the Emergency Department), published by Januzzi and colleagues in 2005, established NT-proBNP cutoffs by age: less than 125 pg/mL for patients under 75 years, and lower thresholds for ruling out heart failure in younger patients. 4 / Promising

For exertional ischemia as a cause of dyspnea, the ACIP (Asymptomatic Cardiac Ischemia Pilot) study data, as well as work by Gibbons and colleagues in the Journal of the American College of Cardiology, established that dyspnea equivalents of ischemia carry the same prognostic weight as typical chest pain. Men who present with exertional dyspnea rather than chest pain are not less sick; they may be more likely to be under-evaluated because their symptom does not match the classic pattern.

Valvular disease data from the Euro Heart Survey on Valvular Heart Disease, published by Lung and colleagues in the European Heart Journal in 2003, showed that dyspnea is the most common presenting symptom in aortic stenosis, present in 51 percent of symptomatic patients, followed by angina and syncope. The onset of symptoms in aortic stenosis is a clinical inflection point: once symptomatic, survival without intervention drops substantially.

For distinguishing cardiac from pulmonary dyspnea, a 2014 systematic review by Morgan and colleagues in Respiratory Medicine evaluated clinical features across 35 studies. Orthopnea (the need to sleep elevated to avoid breathlessness) had specificity of 88 percent for heart failure. Paroxysmal nocturnal dyspnea, waking from sleep breathless, had specificity of 84 percent. These two features, taken together, are highly specific for cardiac cause when present.

Deconditioning produces breathlessness through a different and often underappreciated mechanism. In a deconditioned man, cardiac output reserve is limited, skeletal muscle efficiency is reduced, and aerobic capacity is low. His breathlessness with exertion is real. The challenge is that deconditioning and early heart disease can coexist, and assuming the cause is deconditioning when it is actually heart disease is a clinically dangerous error. The combination of progressive exertional dyspnea, cardiovascular risk factors, and age over 45 should not be attributed to deconditioning without evaluation.

Obesity independently causes dyspnea through several pathways. Excess body mass increases the oxygen cost of physical activity at any given workload. Abdominal fat raises intra-abdominal pressure and limits diaphragm excursion, particularly in recumbent positions. Obesity is also strongly associated with obstructive sleep apnea, which fragments sleep, impairs nighttime autonomic recovery, and can produce daytime symptoms of breathlessness through sleep-related hypoxemia and cardiovascular strain. In obese men with dyspnea, the evaluation must distinguish whether obesity is the primary cause, a contributing factor, or simply a bystander in a presentation that is fundamentally cardiac.

One clinical tool that helps stratify severity of exertional dyspnea without sophisticated equipment is the six-minute walk test. The patient walks at his own pace for six minutes, and the distance covered is recorded. Normal values depend on age, height, and weight, but the test provides a reproducible functional baseline. Repeat testing after treatment gives objective evidence of whether the intervention improved functional capacity. In men with suspected heart failure, the six-minute walk test distance also carries independent prognostic significance.

Psychological anxiety and panic disorder can produce breathlessness that is difficult to distinguish from cardiac dyspnea on history alone. Anxiety-related dyspnea often appears episodically, may occur at rest rather than during exertion, and is frequently accompanied by an inability to take a satisfying deep breath. It commonly presents alongside other autonomic symptoms: palpitations, tingling in the extremities, chest tightness, and a sense of impending doom. The clinical challenge is that anxiety and cardiac disease coexist frequently, particularly in middle-aged men who have experienced a cardiac event or who carry significant cardiovascular risk. The appropriate clinical approach is to evaluate both possibilities in parallel rather than attributing the symptom to anxiety before cardiac causes have been excluded.

Clinical features that favor cardiac over non-cardiac cause, based on the evidence base discussed above, form a practical clinical checklist. Cardiac dyspnea is more likely when: exertional breathlessness is progressive over months, orthopnea or paroxysmal nocturnal dyspnea is present, bilateral ankle edema is present, and the man carries cardiovascular risk factors. Non-cardiac dyspnea is more likely when: wheeze or cough accompanies the dyspnea, the symptom is worse with specific allergen or environmental triggers, it is present first thing in the morning and improves through the day, or there is a strong history of smoking or prior pulmonary disease. These are probabilities, not certainties. The evaluation uses these clinical features to prioritize the diagnostic path, not to bypass it.

BNP and NT-proBNP: The Biomarker That Cuts Through the Differential

Among the laboratory tests that immediately narrow the differential diagnosis for dyspnea, B-type natriuretic peptide (BNP) and its inactive precursor fragment NT-proBNP are the most clinically decisive. Both are released by ventricular myocytes in response to increased wall stress from volume or pressure overload — the same physiological conditions that produce heart failure. Their measurement takes hours, costs less than most imaging studies, and provides a direct biochemical signal from the stressed myocardium that no other initial test provides.

The Breathing Not Properly Multinational Study, published in the New England Journal of Medicine in 2002 by Maisel and colleagues, enrolled 1,586 patients presenting to emergency departments with acute dyspnea and measured BNP at presentation, blinded from the clinical team. At a threshold of 100 pg/mL, BNP demonstrated sensitivity of 90 percent and specificity of 76 percent for heart failure as the primary diagnosis, with an area under the receiver operating curve of 0.91 — superior to any other single clinical variable or combination examined. The negative predictive value for BNP below 50 pg/mL was 96 percent, meaning a level below this threshold made heart failure as the cause of dyspnea highly unlikely. 5 / Solid

The PRIDE study, published by Januzzi and colleagues in the Journal of the American College of Cardiology in 2005, established age-stratified NT-proBNP thresholds with similar diagnostic accuracy. Age stratification matters because older patients have higher baseline NT-proBNP due to reduced renal clearance and greater cardiac mass, and applying a single threshold to all age groups reduces specificity substantially in elderly patients.

The clinical value of BNP is most apparent when the presentation is ambiguous. A man with progressive dyspnea who also smokes and has poorly controlled hypertension could have heart failure, COPD exacerbation, pulmonary hypertension, or deconditioning. An ECG and chest X-ray provide supporting information but cannot definitively distinguish these. A BNP of 32 pg/mL in this patient shifts probability substantially away from heart failure, directing evaluation toward pulmonary or metabolic causes. A BNP of 680 pg/mL in the same patient immediately elevates heart failure to the primary working diagnosis and initiates the appropriate response: diuresis trial, echocardiography, and urgent electrolyte and renal function assessment.

BNP is also prognostic. Elevated BNP at presentation predicts adverse outcomes independent of the final diagnosis, and serial measurements during heart failure treatment track response to therapy in a way that symptoms alone cannot capture.

What to Do This Week

1. If your exercise tolerance has declined noticeably over the past six to twelve months, and activities that were previously easy now produce breathlessness, schedule a physician visit this week and use specific language: “My exercise tolerance has declined progressively over the past year. I become short of breath at activities that did not affect me before.”

2. Ask specifically for a BNP or NT-proBNP blood test in addition to an ECG. These two tests together take minutes and cost little. A normal BNP and a normal ECG significantly reduce the probability that your dyspnea is from heart failure or a major arrhythmia.

3. Document two specific features before your appointment: whether you can lie flat comfortably to sleep, and whether you have ever woken at night feeling short of breath. These two questions are among the most diagnostically useful in cardiology. Your physician needs this information.

4. If you have any of the following risk factors: hypertension, diabetes, elevated cholesterol, a family history of heart disease, or prior cardiac events, request an echocardiogram as part of the evaluation rather than waiting to see if simpler tests are abnormal first. The threshold for echocardiography should be lower in men with cardiovascular risk factors.

5. If your dyspnea resolves completely within two to three minutes of stopping activity and returns consistently with similar levels of exertion, this pattern is consistent with exertional ischemia and warrants evaluation with an exercise stress test, not just a resting ECG.

Distinguishing cardiac from pulmonary and other causes of breathlessness is possible with clinical history, a focused physical examination, and a small number of targeted tests. The window between symptom onset and clinical evaluation is the window where early intervention changes the trajectory. That window should not remain open for years while a man attributes the change to aging.